Genetic Epidemiology

遗传流行病学

• 批准号: 10007396
• 负责人: ALISA GOLDSTEIN
• 金额: $ 73.46万
• 依托单位: DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10007396
• 关键词: Age; Area; Asians; Attention; Autoimmune Diseases; Autoimmunity; BRAF gene; Blood; Brain; Breast Cancer Genetics; Breast Cancer Patient; Breast Cancer Risk Factor; Canada; Cancer Hospital; Candidate Disease Gene; Case-Control Studies; Categories; Cells; Characteristics; Childhood Medulloblastomas; China; Chinese People; Chordoma; Chronic; Clinic; Clinical; Cohort Effect; Comorbidity; Complement; Complex; Country; Cutaneous Melanoma; DNA; Data; Dentistry; Development; Dysplastic Nevus; Eating; Embryo; Epidemiologist; Estrogen Receptor Status; Estrogen receptor negative; Estrogen receptor positive; Estrogens; Etiology; Exposure to; Expression Profiling; Family; Family Study; Family history of; General Population; Genes; Genetic; Genetic Diseases; Genetic Research; Goals; Hematologic Neoplasms; High-Risk Cancer; Hong Kong; Human Microbiome; Immune; Incidence; Individual; Investigation; Italy; Korea; Lesion; Link; Malaysia; Malaysian; Malignant Bone Neoplasm; Malignant Neoplasms; Mammary Neoplasms; Mediating; Medical; Melanocortin 1 Receptor; Melanocytic nevus; Menopausal Status; Metabolism; Molecular; Molecular Profiling; Monoclonal gammopathy of uncertain significance; Morphology; Multiple Myeloma; Mutation; Neoplasm Metastasis; Neoplasms; Nervous system structure; Nevi and Melanomas; Nevus; Normal tissue morphology; Not Hispanic or Latino; Oncogenes; Outcome; Pathogenesis; Pathway interactions; Patients; Pattern; Philadelphia; Play; Polishes; Population; Predisposition; Process; Prognostic Factor; Protocols documentation; Questionnaires; Receptor Gene; Recording of previous events; Registries; Regulation; Reporting; Research Personnel; Rest; Risk; Risk Factors; Role; Rural; Sampling; San Francisco; Sarawak; Scandinavia; Singapore; Site; Skeleton; Skin; Smoker; Somatic Mutation; Spain; Specimen; Stem cells; Structure; Suggestion; Sun Exposure; Sunscreening Agents; Susceptibility Gene; Taiwan; Tea; Terminal Ductal Lobular Unit; Testing; The Sun; Time; Tissue Sample; Tissues; Tumor Subtype; Tumor Tissue; Ulcerative Colitis; United States; United States National Institutes of Health; Universities; Variant; Woman; age effect; base; cancer subtypes; cancer type; carcinogenesis; case control; cdc Genes; cohort; data registry; disorder risk; drinking; early onset; environment related cancer; exome sequencing; follow-up; genetic epidemiology; genome wide association study; high risk; human disease; individualized medicine; malignant breast neoplasm; medical schools; melanoma; microbiome; molecular subtypes; neoplasm registry; non-smoker; older women; oral microbiome; parity; population based; preservation; rare variant; rate of change; receptor; risk variant; tanning booths; telomere; tumor; tumor DNA; young woman

Many of the investigations in this genetic epidemiology project arise from observations in families at high risk of cancer or in other etiologic studies.Analyses of a case-control study of 718 non-Hispanic white patients with cutaneous melanoma from melanoma clinics in Philadelphia and San Francisco showed modest, non-significant decreased risk of melanoma among susceptible individuals who used sunscreens most of the time. Young women were the individuals most likely to use tanning beds, and use was related to melanoma risk. Those who used tanning beds were more likely to have melanomas in sites not usually exposed to sun. These observations may help explain the increasing rates and changing distribution of melanoma among young women in the general population. Questionnaire data, tumor, and DNA from a case-control study of 183 incident melanoma cases and 179 controls conducted in North-Eastern Italy, showed a strong association between germline variants in the melanocortin-1 receptor (MC1R) gene and melanoma with somatic mutations in the BRAF oncogene, in subjects with melanoma arising on sun exposed areas of the body and with limited chronic solar damage. We confirmed this association in an independent population. Data from other Mediterranean populations have been collected and harmonized to extend the analyses of association between melanoma risk and several risk factors, also including immune-related genes. In this combined sample, we identified suggestive evidence for a role of telomere-related genes in the etiology of melanoma. Moreover, a genome-wide association study (GWAS) of melanoma cases from Mediterranean countries and appropriate controls is ongoing. A polygenic risk score analysis using the GWAS data and additional data from melanoma consortia is also ongoing. Melanoma tissue specimens have been collected and analyses of melanoma lesions in relation to sun exposure, body site, nevi count, susceptibility genes and molecular alterations is planned. One of the potential pathways that leads to the development of melanoma includes the loss of regulation of common melanocytic nevi, which acquire atypic or dysplastic characteristics that can further evolve in neoplasia. To study this pathway, we are currently collecting multiple tissue samples of normal skin, common melanocytic nevi, dysplastic nevi, melanoma and metastasis from melanoma from the same subjects from Italy and Spain. We are planning to study the expression and presence of mutations in multiple genes of the cell cycle, and transduction pathways in the serial tissue samples and germline DNA to explore the mechanisms involved in melanoma development through nevi. Chordoma is a rare primary malignant bone tumor that arises mainly in the axial skeleton from rests of embryonic notochordal stem cells that failed to undergo normal regression. A project was developed to collect personal and family medical history, buccal cells and tumor tissue from sporadic chordoma patients from the United States and Canada. Using DNA from 100 sporadic chordoma patients in this study, we identified several common and rare variants in the T gene that are related to disease risk, providing more evidence for the importance of the T gene in the pathogenesis of both familial and sporadic chordoma. Currently, we are using whole-exome sequencing (WES) to identify additional susceptibility genes in chordoma families without T duplication and sporadic chordoma cases. The WES analysis identified several genes that are potentially related to chordoma predisposition and functional follow-up is in process. We are also collaborating with cancer hospitals in Beijing, China to collect germline DNA and chordoma tumor tissues from Chinese chordoma patients to follow up on variants we identify from the WES project. Alterations in the normal microbiome are increasingly recognized to play a role in human disease. Using protocols adapted from the NIH Human Microbiome Project, we conductedpilot studies with investigators from the School of Medicine and Dentistry, University of Rochester to evaluate differences in the oral microbiome between smokers and nonsmokers. Analysis of the resultant microbiome data is in progress. Using data we collected from the Polish Breast Cancer Study and breast cancer association consortium, we demonstrated that risk factors for breast cancer and morphology and molecular characteristics of terminal duct lobular units (TDLUs), the structures from which breast cancers arise, varied by molecular subtypes. In addition, we found that parity-related molecular changes were preserved in breast cancer patients with ER-positive tumors but disrupted in patients with ER-negative tumors, a finding that may partially account for the observed differential effect of parity in these two tumor subtypes. We are currently analyzing the expression profiling data to identify molecular signatures for TDLU involution and parity. Recently, we initiated several breast cancer projects with clinicians and epidemiologists in Asian countries to study breast cancer among Asian women. Using data collected from Sarawak, Malaysia, we showed that the overrepresentation of early-onset and ER-negative tumors among Malaysian women was largely due to the disproportionally lower incidence of late-onset ER-positive tumors rather than an absolute increase in ER-negative cancers. We extended this finding using cancer registry data from several Asian countries (Singapore, Taiwan, Hong Kong, China, Korea) and reported that, after the adjustment of period and cohort effects, the age effects of breast cancer may be more similar between Asian and Western women than previously recognized. Our results also showed that rapidly rising cohort specific rates have narrowed the historic disparity between Chinese and US NHW breast cancer populations, particularly in regions with the lowest baseline rates (such as rural China) and among older women. We developed a new tissue-based breast cancer study in Hong Kong, and plan to collect breast tumor and adjacent normal tissues from up to 1,000 breast cancer cases with the goal of identifying molecular changes that are related to risk and clinical factors for breast cancer subtypes among Chinese women in Hong Kong. Using the Hong Kong data we collected, we found a complex relationship between tea drinking and breast cancer risk that is modified by menopausal status, age at tea drinking, and possibly ER status. We also identified an interesting association between nighttime eating and increased breast cancer risk among Hong Kong women.We are continuing to conduct studies of hematologic malignancies using the Swedish linked registry data to complement the family studies in GEB. However, the current level of activity of these studies is low. We have recently completed a study with some additional data added which describes the effect of prior autoimmune diseases on survival of patients with MGUS and multiple myeloma (MM). As expected, in control individuals, autoimmune diseases lower overall survival. We also found that survival of MGUS and MM patients was decreased in patients with pre-existing autoimmune diseases. When analyzing different types of autoimmune diseases, a history of ulcerative colitis had a stronger impact on survival in MM than in controls. Our findings that a history of autoimmune disease has a negative impact on survival in MM and MGUS could be due to shared underlying common genetic factors, or that patients with a personal history of autoimmunity develop more severe cases of MM and MGUS, or cumulative comorbidity in the individual. Our results suggest that more attention should be paid to comorbidity as a prognostic factor in MGUS and MM, and underlines the need for studies aimed at tailoring therapy according to comorbidity.

该遗传流行病学项目中的许多调查都来自对癌症高风险家庭的观察或其他病因学研究。对来自费城和旧金山黑色素瘤诊所的 718 名患有皮肤黑色素瘤的非西班牙裔白人患者进行的病例对照研究分析显示，大部分时间使用防晒霜的易感人群患黑色素瘤的风险适度、非显着降低。年轻女性是最有可能使用日光浴床的人，使用日光浴床与黑色素瘤风险相关。使用日光浴床的人在通常不接触阳光的部位更容易患黑色素瘤。这些观察结果可能有助于解释一般人群中年轻女性黑色素瘤发病率的增加和分布的变化。在意大利东北部对 183 例黑色素瘤病例和 179 例对照进行的病例对照研究中的问卷数据、肿瘤和 DNA 显示，在身体暴露于阳光的部位出现黑色素瘤且慢性日光损伤有限的受试者中，黑皮质素-1 受体 (MC1R) 基因的种系变异与 BRAF 癌基因体细胞突变的黑色素瘤之间存在密切关联。我们在独立人群中证实了这种关联。来自其他地中海人群的数据已被收集和协调，以扩展黑色素瘤风险与多种风险因素（还包括免疫相关基因）之间关联的分析。在这个组合样本中，我们发现了端粒相关基因在黑色素瘤病因学中的作用的提示性证据。此外，一项针对地中海国家黑色素瘤病例和适当对照的全基因组关联研究（GWAS）正在进行中。使用 GWAS 数据和黑色素瘤联盟的其他数据进行的多基因风险评分分析也在进行中。已经收集了黑色素瘤组织标本，并计划对与阳光照射、身体部位、痣计数、易感基因和分子改变相关的黑色素瘤病变进行分析。导致黑色素瘤发展的潜在途径之一包括常见黑色素细胞痣调节的丧失，这种痣获得非典型或发育不良的特征，并可在肿瘤中进一步进化。为了研究这一途径，我们目前正在收集来自意大利和西班牙同一受试者的正常皮肤、常见黑素细胞痣、发育不良痣、黑色素瘤和黑色素瘤转移的多个组织样本。我们计划研究细胞周期多个基因中突变的表达和存在，以及系列组织样本和种系 DNA 中的转导途径，以探索通过痣发展黑色素瘤的机制。脊索瘤是一种罕见的原发性恶性骨肿瘤，主要由未能正常消退的胚胎脊索干细胞的其余部分产生于中轴骨骼。开发了一个项目来收集来自美国和加拿大的散发性脊索瘤患者的个人和家族病史、口腔细胞和肿瘤组织。在本研究中，我们使用来自 100 名散发性脊索瘤患者的 DNA，鉴定了 T 基因中与疾病风险相关的几种常见和罕见变异，为 T 基因在家族性和散发性脊索瘤发病机制中的重要性提供了更多证据。目前，我们正在使用全外显子组测序 (WES) 来识别无 T 重复和散发脊索瘤病例的脊索瘤家族中的其他易感基因。 WES 分析确定了几个可能与脊索瘤易感性相关的基因，功能随访正在进行中。我们还与中国北京的癌症医院合作，收集中国脊索瘤患者的种系 DNA 和脊索瘤肿瘤组织，以追踪我们从 WES 项目中识别出的变异。人们越来越认识到正常微生物组的改变在人类疾病中发挥着作用。使用改编自 NIH 人类微生物组项目的方案，我们与罗切斯特大学医学和牙科学院的研究人员进行了试点研究，以评估吸烟者和非吸烟者之间口腔微生物组的差异。由此产生的微生物组数据的分析正在进行中。利用我们从波兰乳腺癌研究和乳腺癌协会联盟收集的数据，我们证明了乳腺癌的危险因素以及终末导管小叶单位（TDLU）（乳腺癌产生的结构）的形态和分子特征因分子亚型而异。此外，我们发现，与胎次相关的分子变化在ER阳性肿瘤的乳腺癌患者中得以保留，但在ER阴性肿瘤患者中被破坏，这一发现可能部分解释了在这两种肿瘤亚型中观察到的胎次差异效应。我们目前正在分析表达谱数据，以确定 TDLU 复合和奇偶校验的分子特征。最近，我们与亚洲国家的临床医生和流行病学家启动了几个乳腺癌项目，以研究亚洲女性的乳腺癌。 使用从马来西亚沙捞越州收集的数据，我们发现马来西亚女性中早发性和 ER 阴性肿瘤的比例过高，很大程度上是由于晚发 ER 阳性肿瘤的发病率不成比例地较低，而不是 ER 阴性癌症的绝对增加。我们使用来自几个亚洲国家（新加坡、台湾、香港、中国、韩国）的癌症登记数据扩展了这一发现，并报告说，在调整时期和队列效应后，亚洲和西方女性之间乳腺癌的年龄影响可能比之前认识的更为相似。我们的结果还表明，快速上升的队列特定发病率缩小了中国和美国 NHW 乳腺癌人群之间的历史差距，特别是在基线发病率最低的地区（例如中国农村）和老年女性。我们在香港开展了一项新的基于组织的乳腺癌研究，并计划从多达 1,000 例乳腺癌病例中收集乳腺肿瘤和邻近正常组织，目的是确定与香港华人女性乳腺癌亚型风险和临床因素相关的分子变化。利用我们收集的香港数据，我们发现饮茶与乳腺癌风险之间存在复杂的关系，这种关系会受到更年期状况、饮茶年龄以及可能的 ER 状态的影响。我们还发现香港女性夜间进食与乳腺癌风险增加之间存在有趣的关联。我们正在继续使用瑞典关联的登记数据进行血液恶性肿瘤研究，以补充 GEB 的家庭研究。然而，目前这些研究的活跃程度较低。我们最近完成了一项研究，添加了一些额外的数据，描述了既往自身免疫性疾病对 MGUS 和多发性骨髓瘤 (MM) 患者生存的影响。 正如预期的那样，在对照个体中，自身免疫性疾病会降低总体生存率。我们还发现，患有自身免疫性疾病的 MGUS 和 MM 患者的生存率降低。在分析不同类型的自身免疫性疾病时，溃疡性结肠炎病史对多发性骨髓瘤患者的生存影响比对照组更大。我们的研究结果表明，自身免疫病史对 MM 和 MGUS 的生存产生负面影响，这可能是由于共同的潜在共同遗传因素，或者有自身免疫病史的患者会出现更严重的 MM 和 MGUS 病例，或者是个体累积合并症。我们的结果表明，应更多地关注合并症作为 MGUS 和 MM 的预后因素，并强调需要进行旨在根据合并症调整治疗的研究。